Published in AIDS Res Hum Retroviruses on December 01, 1992
Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J Virol (1994) 3.32
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev (2008) 3.16
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. J Virol (2001) 2.16
Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Proc Natl Acad Sci U S A (1994) 2.09
Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J Virol (1997) 2.08
Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. J Virol (1996) 1.57
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J Virol (1997) 1.31
Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J Virol (1995) 1.19
Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association. J Virol (2001) 1.15
Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J Virol (1996) 1.07
Changes in the cytopathic effects of human immunodeficiency virus type 1 associated with a single amino acid alteration in the ectodomain of the gp41 transmembrane glycoprotein. J Virol (1994) 0.99
Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies. J Virol (2012) 0.81
Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India. PLoS One (2012) 0.80
Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers. J Virol (1998) 0.76
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol (1991) 6.72
Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science (1987) 5.23
Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem (1977) 4.87
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (1987) 4.09
AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett (1999) 3.63
Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem (1998) 3.53
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1986) 3.49
Mammalian AMP-activated protein kinase subfamily. J Biol Chem (1996) 3.47
Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res (2001) 3.18
Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A (1987) 3.06
Structural basis of autoregulation of phenylalanine hydroxylase. Nat Struct Biol (1999) 2.67
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J Biol Chem (1994) 2.57
Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem (2001) 2.56
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci (2001) 2.51
The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol (1999) 2.42
Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal Biochem (1978) 2.33
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. J Biol Chem (1992) 2.22
Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J Biol Chem (1998) 2.10
Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem (2001) 2.04
Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem (1999) 1.99
Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem (1996) 1.93
Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest (2000) 1.86
Ca2+/S100 regulation of giant protein kinases. Nature (1996) 1.86
The influence of basic residues on the substrate specificity of protein kinase C. J Biol Chem (1987) 1.80
Substrate specificity of a multifunctional calmodulin-dependent protein kinase. J Biol Chem (1985) 1.80
Synthetic hexapeptide substrates and inhibitors of 3':5'-cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1976) 1.75
The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. J Biol Chem (1987) 1.72
Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J (2001) 1.69
Substrate specificity of the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1975) 1.68
An activating mutation in the gamma1 subunit of the AMP-activated protein kinase. FEBS Lett (2001) 1.65
Regulatory and structural motifs of chicken gizzard myosin light chain kinase. Proc Natl Acad Sci U S A (1990) 1.62
Calcium/calmodulin-dependent protein kinase II. Characterization of distinct calmodulin binding and inhibitory domains. J Biol Chem (1988) 1.60
Insights into autoregulation from the crystal structure of twitchin kinase. Nature (1994) 1.55
Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J Biol Chem (1994) 1.50
Posttranslational modifications of the 5'-AMP-activated protein kinase beta1 subunit. J Biol Chem (1997) 1.49
Functional analysis of a complementary DNA for the 50-kilodalton subunit of calmodulin kinase II. Science (1987) 1.48
Mutagenesis of the pseudosubstrate site of protein kinase C leads to activation. Eur J Biochem (1990) 1.47
Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein. Protein Sci (1998) 1.45
AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab (2000) 1.41
Proteolysis of smooth muscle myosin light chain kinase. Formation of inactive and calmodulin-independent fragments. J Biol Chem (1987) 1.39
Active site-directed protein regulation. Nature (1999) 1.37
Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated protein kinase. J Biol Chem (1996) 1.37
Phosphorylation site sequence of smooth muscle myosin light chain (Mr = 20 000). FEBS Lett (1984) 1.31
Structural basis of the intrasteric regulation of myosin light chain kinases. Science (1992) 1.31
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J Virol (1997) 1.31
Effects of modulators of myosin light-chain kinase activity in single smooth muscle cells. Nature (1989) 1.30
Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology (1981) 1.29
Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Miner Res (1989) 1.28
AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett (1997) 1.28
Design and use of peptide substrates for protein kinases. Methods Enzymol (1991) 1.28
Role of basic residues in the phosphorylation of synthetic peptides by myosin light chain kinase. Proc Natl Acad Sci U S A (1983) 1.26
Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem (2000) 1.26
Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys (2000) 1.25
Giant protein kinases: domain interactions and structural basis of autoregulation. EMBO J (1996) 1.24
Substrate specificities for yeast and mammalian cAMP-dependent protein kinases are similar but not identical. J Biol Chem (1991) 1.24
Autoregulation of enzymes by pseudosubstrate prototopes: myosin light chain kinase. Science (1988) 1.23
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer (2004) 1.23
Identification of substrate specificity determinants for the cell cycle-regulated NIMA protein kinase. J Biol Chem (1994) 1.21
Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J Virol (1995) 1.19
Isoform-specific purification and substrate specificity of the 5'-AMP-activated protein kinase. J Biol Chem (1996) 1.19
Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett (1999) 1.19
The myosin-I-binding protein Acan125 binds the SH3 domain and belongs to the superfamily of leucine-rich repeat proteins. Proc Natl Acad Sci U S A (1997) 1.17
Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem (1986) 1.16
Endothelium and the vasodilator action of rat calcitonin gene-related peptide (CGRP). Br J Pharmacol (1987) 1.14
Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. J Biol Chem (2001) 1.13
ADR1c mutations enhance the ability of ADR1 to activate transcription by a mechanism that is independent of effects on cyclic AMP-dependent protein kinase phosphorylation of Ser-230. Mol Cell Biol (1992) 1.13
The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J Biol Chem (1999) 1.13
Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J Physiol (2009) 1.13
Pseudosubstrate-based peptide inhibitors. Methods Enzymol (1991) 1.11
Progressive increase in human skeletal muscle AMPKalpha2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab (2002) 1.10
Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J Virol (2000) 1.08
Catalytic subunits of the porcine and rat 5'-AMP-activated protein kinase are members of the SNF1 protein kinase family. Biochim Biophys Acta (1995) 1.07
Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia (2009) 1.06
Regulation of intrasteric inhibition of the multifunctional calcium/calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A (1992) 1.05
Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase. Biochemistry (1985) 1.04
Structure and function of AMP-activated protein kinase. Acta Physiol (Oxf) (2009) 1.04
Two apparent molecular weight forms of human and monkey phenylalanine hydroxylase are due to phosphorylation. J Biol Chem (1984) 1.04
A synthetic peptide analog of the putative substrate-binding motif activates protein kinase C. FEBS Lett (1989) 1.03
Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood. Science (1988) 1.03
Phosphorylation of myelin basic protein by an adenosine 3':5'-cyclic monophosphate-dependent protein kinase. Biochem J (1973) 1.03
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes (2000) 1.03
AMP-Activated protein kinase is activated by the stimulations of G(q)-coupled receptors. Biochem Biophys Res Commun (2000) 1.02
Effect of exercise intensity and hypoxia on skeletal muscle AMPK signaling and substrate metabolism in humans. Am J Physiol Endocrinol Metab (2005) 1.02
Problems in the interpretation of diagnostic tests due to cross-reactions between orbiviruses and broad serological responses in animals. Prog Clin Biol Res (1985) 1.01
Regulation and crystallization of phosphorylated and dephosphorylated forms of truncated dimeric phenylalanine hydroxylase. Protein Sci (1997) 1.00
Peptide inhibitors of cAMP-dependent protein kinase. Methods Enzymol (1988) 1.00
Serological detection of attenuated HIV-1 variants with nef gene deletions. AIDS (1998) 0.99
Substrate specificity of phospholipid/Ca2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. J Biol Chem (1985) 0.99
Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino acid sequence. J Biol Chem (1996) 0.99
Mapping of calmodulin-binding domain of Ca2+/calmodulin-dependent protein kinase II from rat brain. Biochem Biophys Res Commun (1988) 0.98
Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies. AIDS (1990) 0.96
Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences. J Virol (1997) 0.95